Algert Global LLC Rocket Pharmaceuticals, Inc. Transaction History

Algert Global LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $414,633 - $789,237	24,710 New	24,710 $741,000
Q4 2022 Feb 13, 2023	SELL	$15.5 - $22.76 $27,280 - $40,057	-1,760 Reduced 3.42%	49,768 $974,000
Q3 2022 Nov 15, 2022	BUY	$12.37 - $18.41 $133,076 - $198,054	10,758 Added 26.39%	51,528 $822,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $146,941 - $307,174	18,460 Added 82.74%	40,770 $561,000
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $293,599 - $528,300	22,310 New	22,310 $354,000
Q1 2021 May 14, 2021	SELL	$43.34 - $65.91 $402,801 - $612,567	-9,294 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$23.3 - $59.57 $305,859 - $781,975	-13,127 Reduced 58.55%	9,294 $510,000
Q2 2020 Aug 12, 2020	SELL	$13.32 - $22.61 $72,047 - $122,297	-5,409 Reduced 19.44%	22,421 $469,000
Q1 2020 May 13, 2020	BUY	$9.71 - $25.11 $270,229 - $698,811	27,830 New	27,830 $388,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.